| |
|
|
 |
|
print
|
|
|
|
|
Overview: A Window Into the Future
|
|
click to enlarge |
Development risk and attrition rates remain two of the greatest challenges to a successful biopharmaceutical pipeline. To help its customers mitigate both aspects, Lonza launched Applied Protein Services -- a platform of immunogenicity, stability and protein engineering services that provides a window into the future of a biologic. With this capability, the newly integrated Applied Protein Services platform is able to improve the quality, safety, efficacy and manufacturability of antibodies, therapeutic proteins and vaccines.
|
Core Technologies |
| Applied Protein Services is a platform of immunogenicity screening, stability and protein engineering services.
Algonomics Epibase™ & Epibase IV™
Computer-based and cellular immunoprofiling for lead selection, lead comparison, optimization and surveillance
Tripole™ Protein Engineering
Technology platform for protein structure analysis, modeling, engineering, deimmunization and antibody optimization
AggreSolve™
An integrated in vitro-in silico technology platform to help resolve protein aggregation and stability challenges |
Improve Your Biologic Development Success
|
|
click to enlarge |
The Applied Protein Services platform is effective at improving the quality, safety, efficacy and manufacturability of antibodies, therapeutic proteins, peptides and vaccines. By supporting the successful selection, optimization and early process development of promising drug candidates, Lonza’s Applied Protein Services improves your likelihood of biologic development success.
|
|
|
|
|
|
|
|
|
 |
;)
;)
